| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 11 |
| 1 | MYCOPHENOLATE MOFETIL | 10 |
| 2 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 10 |
| 3 | CYCLOPHOSPHAMIDE | 8 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 8 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 8 |
| 6 | RITUXIMAB | 8 |
| 7 | TACROLIMUS | 8 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 7 |
| 9 | TACROLIMUS OINTMENT 0.1% | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLINDAMYCIN PHOSPHATE TOPICAL | 3 | 0.0008 |
| 1 | DOBUTAMINE HYDROCHLORIDE | 1 | 0.0008 |
| 2 | INOTUZUMAB OZOGAMICIN | 2 | 0.0007 |
| 3 | AMINOLEVULINIC ACID HYDROCHLORIDE | 1 | 0.0006 |
| 4 | CLINDAMYCIN PHOSPHATE | 3 | 0.0005 |
| 5 | ANIFROLUMAB-FNIA | 1 | 0.0005 |
| 6 | IVABRADINE | 3 | 0.0004 |
| 7 | LETERMOVIR | 1 | 0.0003 |
| 8 | CABOTEGRAVIR AND RILPIVIRINE | 2 | 0.0003 |
| 9 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 3 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 2 | 0.0007 |
| 1 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 2 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 3 | Allylamine Antifungal [EPC] | 2 | 0.0003 |
| 4 | Thyroid Hormone Synthesis Inhibitor [EPC] | 2 | 0.0002 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 6 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 8 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 9 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |